|
ABCD4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.829800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.214600E-01 |
| Normal-vs-Stage2 |
3.735800E-01 |
| Normal-vs-Stage3 |
5.598800E-01 |
| Normal-vs-Stage4 |
2.970200E-02 |
| Stage1-vs-Stage2 |
6.575800E-01 |
| Stage1-vs-Stage3 |
6.924000E-01 |
| Stage1-vs-Stage4 |
1.011550E-01 |
| Stage2-vs-Stage3 |
9.571400E-01 |
| Stage2-vs-Stage4 |
1.799010E-01 |
| Stage3-vs-Stage4 |
3.233000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.524200E-01 |
| Normal-vs-AfricanAmerican |
6.061600E-01 |
| Normal-vs-Asian |
3.942000E-01 |
| Caucasian-vs-AfricanAmerican |
5.821400E-01 |
| Caucasian-vs-Asian |
5.478000E-01 |
| AfricanAmerican-vs-Asian |
6.950800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.598000E-01 |
| Normal-vs-Female |
2.519400E-01 |
| Male-vs-Female |
1.309990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.953800E-01 |
| Normal-vs-Extreme_Weight |
7.252000E-01 |
| Normal-vs-Obese |
5.757200E-01 |
| Normal-vs-Extreme_Obese |
8.812200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.991800E-01 |
| Normal_Weight-vs-Obese |
7.491000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.676800E-01 |
| Extreme_Weight-vs-Obese |
7.931000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.592400E-01 |
| Obese-vs-Extreme_Obese |
6.815400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.853960E-01 |
| Normal-vs-Age(41-60Yrs) |
5.790400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.833800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.966800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.574040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.819800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.061000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.540190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.785800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.404400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.046440E-01 |
| Normal-VS-Type2 PRCC |
1.570580E-01 |
| Normal-VS-KIRP CIMP |
1.21779999995297E-06 |
| Normal-VS-Unclassified PRCC |
2.542800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.259520E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.91760000498331E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
2.684200E-03 |
| Type2 PRCC-VS-KIRP CIMP |
2.21779999999283E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
9.520000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.247780E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.491600E-01 |
| Normal-vs-N1 |
2.424400E-01 |
| Normal-vs-N2 |
8.36800000000304E-05 |
| N0-vs-N1 |
5.442200E-01 |
| N0-vs-N2 |
7.642000E-03 |
| N1-vs-N2 |
1.038800E-01 |
|
|
